Oh if only...



Societe Generale today reaffirms its buy investment rating on AstraZeneca PLC (LON:AZN) and set its price target at 7800p. Story provided by Broker Forecasts data provided by


Maybe they remember back to when Pfizer were willing to offer £55 in 2014, they may be thinking they’ll be back or the promise to " raise revenues by more than three quarters over the next decade" may be about to start kicking in.

Thanks for the update, appreciated.